Portfolio company
EXIMO
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops hybrid catheter technology for tissue resection in vascular and gastrointestinal endoluminal applications for healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AtheroMed
This company develops a catheter system that removes plaque from arteries for physicians treating patients with peripheral artery disease.
ENDOVASCULAR DEVICES
This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.
Digma Medical
This company develops endoscopic laser ablation platforms for gastrointestinal diseases and metabolic conditions for hospitals and specialist medical providers.
Endogenex
This company develops an endoscopic system using pulsed electric fields to treat type 2 diabetes by regenerating signalling cells in the small intestine.
CAD TREATMENT OPTIMIZATION
This medical technology company develops advanced intravascular imaging systems to help cardiologists assess and treat coronary artery disease in patients.
THROMBECTOMY SYSTEMS
This company develops catheter-based clot removal systems for physicians treating patients with venous thromboembolism, deep vein thrombosis and pulmonary embolism.
ChamberTech
The company develops a hybrid ablation catheter system to treat patients with persistent atrial fibrillation by targeting both endocardial and epicardial heart surfaces.
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
